SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-23-048427
Filing Date
2023-04-21
Accepted
2023-04-21 16:30:28
Documents
6
Period of Report
2023-06-12

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm232157-1_pre14a.htm PRE 14A 745913
2 GRAPHIC lg_checkpointthera-4c.jpg GRAPHIC 168247
3 GRAPHIC px_01pgprxy-bw.jpg GRAPHIC 681765
4 GRAPHIC px_02pgprxy-bw.jpg GRAPHIC 789248
5 GRAPHIC sg_garrettgray-bw.jpg GRAPHIC 9851
6 GRAPHIC sg_jamesfoliviero-bw.jpg GRAPHIC 10884
  Complete submission text file 0001104659-23-048427.txt   2736630
Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38128 | Film No.: 23836755
SIC: 2834 Pharmaceutical Preparations